Categories: All postsAnalysts

VIQ Solutions has 72% upside: Echelon Wealth Partners

Following a potentially lucrative new partnership, Echelon Wealth Partners analyst Ralph Garcea is maintaining his bullish take on VIQ Solutions (VIQ Solutions Stock Quote, Chart, News: TSXV:VQS).

This morning, VIQ announced it will partner with University of Virginia Medical Center, a medical trauma centre, for VIQ’s satellite audio-video capture, management and collaborative Web portal solution.

“This collaborative project with the esteemed University of Virginia Medical Center is a significant win for VIQ in United States health care,” CEO Sebastien Pare said. “It is a partnership dedicated to enhancing the quality of care to trauma patients with our technology, which is focused on procedural and performance analysis. VIQ satellite securely captures multipoint audio-video (AV), and sensor data with several layers of added functionality, including cybersecurity, data analytics and a collaboration web portal,” said , president and chief executive officer of VIQ Solutions. This breakthrough materially advances VIQ’s growing international reputation in the markets we’re focused on, namely health care, public safety, justice and law enforcement. VIQ’s leading-edge digital-media solutions are designed to meet the exacting demands of these markets while maintaining the highest level of security and privacy for their digital content.”

Garcea says VIQ has the wind at its back.

“With increasingly more content being recorded and digitized in the cloud on a daily basis, VIQ has become a direct beneficiary of this trend,” the analyst says. “The Company focuses on developing software solutions with the highest level of cybersecurity that appeal to security and privacy conscious organizations that collect sensitive evidence-based digital data. The Company is technology agnostic with respect to the mode of data collection, which opens up a potentially wide partner universe with respect to each market segment it is servicing.”

In a research update to clients today, Garcea maintained his “Speculative Buy” rating and one-year price target of $0.50 on VIQ Solutions, implying a return of 72 per cent at the time of publication.

Garcea thinks VIQ will generate EBITDA of $1.6-million on revenue of $13.1-million in fiscal 2017. He expects those numbers will improve to EBITDA of $2.6-million on a topline of $17.6-million the following year.

Garcea says VIQ is cheap compared to its peers.

“VQS is currently trading at a C2018E EV/Sales of 1.8x and EV/EBITDA of 12.0x versus its Canadian small cap comparables at 1.8x/13.2x, and Video/Audio Capture and AI comparables at 5.9x/15.3x, respectively,” the analyst notes.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: vqs
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

2 days ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

2 days ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

2 days ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

3 days ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

3 days ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

3 days ago